Alt stock news
Home - Alt News Subscribe to Alt News via Email. Enter your email address to subscribe to Alt News and receive notifications of new posts by email. Email Address . Subscribe . Except where otherwise noted, this website is licensed under a Creative Commons Attribution 3.0 Unported License. Content from Facebook is governed by Facebook License for posts that are ALT - Altimmune News - Barchart.com Find recent news headlines for a specific symbol on this page. Van Meerten Stock Picks. Jim Van Meerten's Daily Stock Picks highlights stocks you might want to consider for your portfolio, with Jim's editorials about current events and stock market commentary. Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. Altimmune, Inc (ALT) Stock Message Board - InvestorsHub New message board for Alt. ALT Current Price Volume: Bid Ask Day's Range ALT Price Target | Altimmune Stock Forecast & Ratings
Stock quote for Altimmune, Inc. Common Stock Common Stock (ALT) with real-time last sale and extended hours stock prices, company news, charts, and research at Nasdaq.
NewsSee all news. 30 March 2020 Altimmune and the University of Alabama at Birmingham to Collaborate on Development of Single-Dose, Intranasal COVID-19 Vaccine. GAITHERSBURG, Md., March 30, 2020 (GLOBE NEWSWIRE) -- Altimmune, Inc. (NASDAQ:ALT), a clinical-stage biopharmaceutical company, today announced that it is launching a collaboration with the University of Alabama at Home | Altimmune Our diverse pipeline includes treatments for NASH (ALT-801), chronic Hepatitis B (HepTcell TM), and conjugated immunostimulants for the treatment of cancer (ALT-702).In addition, we are developing intranasal vaccine programs for anthrax and influenza. OTC Markets | ALT
ALT | Stock Snapshot - Fidelity
ALT | Complete Altimmune Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. Get breaking news and analysis on Altimmune, Inc. (ALT) stock, price quote and chart, trading and investing tools. Prev Close 3.35, 52 Wk Low 1.51. Open 2.94, 52 Wk High 4.45. Day Low 2.90, Volume 3.1M. Day High 3.43, Avg 10D Vol 1.5M Find the latest news headlines from Altimmune, Inc. Common Stock (ALT) at Nasdaq.com. Altimmune, Inc. Common Stock (ALT) Stock Quotes - Nasdaq offers stock quotes Latest News. Altimmune Stock Has Major Pipeline Potential Mar 18, 2020. Researching Altimmune (NYSE:ALT) stock? View ALT's stock price, price target, earnings, financials, forecast, insider trades, news, and SEC filings at View the latest Altimmune Inc. (ALT) stock price, news, historical charts, analyst ratings and financial information from WSJ.
View the real-time ALT price chart on Robinhood and decide if you want to buy or sell commission-free. Change the date range, see whether others are buying
27 Mar 2020 Altimmune Inc. (NASDAQ: ALT) reported its earnings results for fiscal-year Wayfair (W) stock looks less attractive despite low price, thanks to
11 Mar 2020 In the two-week short interest period, the stock's share price dropped by about 17.8%. Its 52-week range is $38.90 to $69.24, and it closed at
Is Altimmune Inc (ALT) Stock a Good Buy? - InvestorsObserver Mar 12, 2020 · Altimmune Inc stock is up 8.07% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy.InvestorsObserver’s proprietary ranking system, gives ALT stock a score of 80 out of a possible 100.. That rank is primarily influenced by a long-term technical score of 99. ALT's rank also includes a short-term technical score of 72. ALT Stock Quote - Philab Holdings Corp - Bloomberg Markets Stock analysis for Philab Holdings Corp (ALT) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Altimmune (ALT) To Begin Clinical Testing Of COVID-19 ... (RTTNews) - Shares of Altimmune Inc. (ALT), a clinical-stage biopharmaceutical company, are currently up a whopping 120 percent, following news that the Company has completed the design and ALT - Altimmune Inc. • BioPharmCatalyst
Subscribe to Alt News via Email. Enter your email address to subscribe to Alt News and receive notifications of new posts by email. Email Address . Subscribe . Except where otherwise noted, this website is licensed under a Creative Commons Attribution 3.0 Unported License. Content from Facebook is governed by Facebook License for posts that are ALT - Altimmune News - Barchart.com Find recent news headlines for a specific symbol on this page. Van Meerten Stock Picks. Jim Van Meerten's Daily Stock Picks highlights stocks you might want to consider for your portfolio, with Jim's editorials about current events and stock market commentary. Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations.